Diligence memo · auto-generated · as of July 2, 2026
Neurogene Inc.
Neurogene Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Neurogene Inc. operates in Other, based in NEW YORK.
Sector still resolves to a broad 'Other' bucket, so operating comparables below are weaker than for a tightly-classified peer.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Neurogene Inc. has raised $106M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $69M on 2020-12-15.
Most recent recorded round closed around 2020-12-15.
Valuation (modeled)modeled
Provath models Neurogene Inc. at approximately $1.1B (range $267M–$2.7B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.32× the median modeled value of Series C Other companies in 2019–2021 (190 peers) — value vs value, same stage and era. Within the normal band (132% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 22 months.
Last raise 5.5 yr ago; this sector typically re-raises about every 11 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 1.8× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 97% of Other peers (25015 compared).
Modeled value ranks above 97% of those peers.
Closest niche peers: Lonnie Ray Williams Jr Trust, Ault Life Sciences, Inc., Watchtower Topco, LLC, Watchtower Management Holdco, LLC, Alphaeon 1 LLC.
Peoplefiled
9 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Broad sector classification weakens peer comparison.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.